Education

Timely Topics in Transplantation Webinar Series

December 12, 2016

View Archive

Speaker: Minnie Sarwal, MD, PhD, MRCP, DCH, FRCP • University of California San Francisco
Moderator: Julie Yabu, MD • Stanford University
 

After participating in this webinar, the learner will be able to:

  1. Identify potential biomarkers and assays for diagnosis for rejection and graft injury
  2. Describe the integration of bioinformatics and datasets in transplantation
  3. Design a strategy to prospectively manage transplant patients using biomarkers to preserve organ function

Moderator: Julie Yabu, MD

 

October 21, 2014

Christian Oberkofler, MDUniversity Hospital Zurich
Thomas Mueller, MD, PhDUniversity Hospital Zurich

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Whether you missed the World Transplant Congress or simply did not have time to catch all of the sessions, attend this webinar and get the important clinical highlights from the meeting.

After participating in this webinar, the learner will be able to:

  1. Describe the impact of novel methods of immune monitoring, antibody detection and immune phenotyping on individualized patient treatment
  2. Discuss living donor safety in respect to current publications and concerns
  3. Explain surgical innovations in the field of transplantation – organ perfusion systems, laparoscopic/robotic kidney and uterus transplantation

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Whether you missed the World Transplant Congress or simply did not have time to catch all of the sessions, attend this webinar and get the important clinical highlights from the meeting.

After participating in this webinar, the learner will be able to:

  1. Describe the impact of novel methods of immune monitoring, antibody detection and immune phenotyping on individualized patient treatment
  2. Discuss living donor safety in respect to current publications and concerns
  3. Explain surgical innovations in the field of transplantation – organ perfusion systems, laparoscopic/robotic kidney and uterus transplantation
November 17, 2016

View Archive

Speaker: Stephanie Pouch, MD • The Ohio State University Medical Center
Moderator: Shirish Huprikar, MD • Icahn School of Medicine at Mount Sinai

Multidrug-resistant organisms (MDROs) pose a particular threat to solid organ transplant recipients.  Infections due to these pathogens are associated with significant morbidity and mortality, and current therapeutic options are limited.  

After participating in this webinar, the learner will be able to:

  1. Describe the epidemiology and outcomes of select MDRO infections in solid organ transplant recipients.
  2. Describe an approach to the use of organs from donors colonized or infected with CRE.
  3. Discuss the role of infection control and antimicrobial stewardship in curtailing the spread of MDROs in solid organ transplant recipients. 
May 21, 2014

Read Q&A that wasn't answered during the webinar

 View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Explore the relevance of HLA testing before and after transplant in solid organ transplantation. At the end of this webinar, participants will be able to:

  1. Understand the enhanced methods of HLA typing and antibody detection now available before transplant
  2. Gain insight in determining recipient humoral risk profiles before and after transplant based on available testing
  3. Appreciate the limitations of HLA testing and the importance of context in interpretation

Explore the relevance of HLA testing before and after transplant in solid organ transplantation.

At the end of this webinar, participants will be able to:

  • Understand the enhanced methods of HLA typing and antibody detection now available before transplant
  • Gain insight in determining recipient humoral risk profiles before and after transplant based on available testing
  • Appreciate the limitations of HLA testing and the importance of context in interpretation
November 15, 2016

View Archive

Speaker: Jignesh Patel, MD • Cedars-Sinai Heart Institute
Moderator: Monica Colvin, MD, MS • University of Michigan

The presence of donor specific antibodies predisposes the thoracic allograft to the risk of antibody mediated rejection, chronic graft dysfunction and increased mortality. Optimal outcomes depend upon a comprehensive understanding of the significance of circulating antibodies after transplantation.  What are the best strategies for defining deleterious antibodies, what are the current available therapies to address these and how effective are they?
 

After participating in this webinar, the learner will be able to:
  1. Identify the significance of circulating antibodies in patients awaiting thoracic transplantation or in patients with development of de novo antibodies after transplantation.
  2. Order appropriate tests to detect relevant donor specific antibodies.
  3. Design rational therapies for the treatment of post-thoracic transplant circulating antibodies.
April 23, 2014

View Archive

Read Q&A that was not answered during the webinar

Free to AST members: $25 fee is waived upon logging in during the checkout process.

Join a transplant nephrologist, transplant surgeon, and epidemiologist as they discuss the risk of ESRD in living kidney donors focusing on two recent publications in JAMA and Kidney International. The presenters will provide:

  • A brief overview of risks of living kidney donation known to date
  • Discussion of the study design, methods and statistics in the manuscripts
  • Implications of the manuscripts on living kidney donation and how to discuss risk with living donors in the context of this new information 

Links to manuscripts:

Join a transplant nephrologist, transplant surgeon, and epidemiologist as they discuss the risk of ESRD in living kidney donors focusing on two recent publications in JAMA and Kidney International. The presenters will provide:

  • A brief overview of risks of living kidney donation known to date
  • Discussion of the study design, methods and statistics in the manuscripts
  • Implications of the manuscripts on living kidney donation and how to discuss risk with living donors in the context of this new information
October 18, 2016

VIEW ARCHIVE
 

Read the Q&A that wasn't answered during webinar

Speaker: Peter Nickerson, MD, FRCPC, FCAHS • University of Manitoba
Moderator: Leonardo Riella, MD, PhD • Harvard Medical School

After participating in this webinar, the learner will be able to:

  1. Understand the use and limitations of solid phase assays in identifying anti-HLA antibodies
  2. Describe the natural history and significance of DSA development post-transplant
  3. Discuss novel tools to improve specificity of solid phase assays 
March 19, 2014

View Archive

Free to AST members: $25 fee is waived upon logging in during the checkout process.

What you'll learn:

  1. Describe the common targets for direct acting antiviral therapy for HCV
  2. Understand current side effects and cure rates to therapy for HCV in liver transplant patients
  3. Discuss all oral DAA drug cocktails for HCV that can and will be used in the near future in transplant patients

What you'll learn:

  • Describe the common targets for direct acting antiviral therapy for HCV
  • Understand current side effects and cure rates to therapy for HCV in liver transplant patients
  • Discuss all oral DAA drug cocktails for HCV that can and will be used in the near future in transplant patients
May 17, 2016

View Archive
 

Read the Q&A that wasn't answered during webinar

Speaker: Rachel Patzer, PhD • Emory Universtiy
Moderator:
Leo Riella, MD, PhD • Harvard Medical School

Significant barriers exist that may prevent patients from successfully navigating the complex transplant process to receive a transplant, including referral for transplant evaluation, starting the transplant evaluation, and completing the steps necessary to be placed on the national deceased donor waiting list or receive a kidney transplantation.  There are several strategies and tools that transplant center physicians and staff members can use to improve patient access to transplantation and reduce disparities.

After participating in this webinar, the learner will be able to:

  1. Understand the key patient- and health system-related barriers in access to multiple steps of the transplantation process
  2. Evaluate the existing evidence-base of approaches for improving patient readiness and access to transplantation
  3. Identify potential solutions that transplant centers can implement to reduce disparities in transplantation access
April 19, 2016

View Archive

Speaker: Mark Aeder, MD • University Hospitals Case Medical Center
Moderator: Nicole Turgeon, MD •  Emory University

The Kidney Allocation System (KAS) was markedly revised on December 4, 2014, resulting in a major early alteration in national kidney distribution. Since a major objective was to provide equity in access to challenged candidates while not compromising vulnerable populations, and allowing for the bolus effects, this presentation will examine first year outcomes and assess the success in meeting the projected KAS goals.

After participating in this webinar, the learner will be able to:

  1. Identify the changes in kidney transplant distribution across recipient categories
  2. Distinguish the changes which will be maintained at a new level following the resolution of the initial bolus effect
  3. Begin to formulate potential modifications to KAS which would further achieve equity in allocation

Moderator: Nicole Turgeon, MD

Pages